DXN Total Bilirubin Reagent - Taiwan Registration 9bb3b47d88e1f60f7bea244381acb9a0
Access comprehensive regulatory information for DXN Total Bilirubin Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9bb3b47d88e1f60f7bea244381acb9a0 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The authorized representative in Taiwan is TUNYEN ENTERPRISE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
In vitro diagnostic reagent for the quantitative determination of total bilirubin in serum or plasma on a photometric system.
A Clinical chemistry and clinical toxicology
A.1110 Bilirubin (total or direct) test system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
May 31, 2022
May 31, 2027